Bamlanivimab Prophylaxis

Jan 21, 2021Podcast0 comments

Using a synthetic monoclonal antibody (Bamlanivimab) may be a good treatment for people in eminent danger of onset of COVID-19 before getting the vaccine.

Send in a voice message:


Submit a Comment

Your email address will not be published. Required fields are marked *